Effect of Early vs Late Water Exposure After Cutaneous Surgery

May 6, 2026 updated by: Saba Khan, Pak Emirates Military Hospital

Effect of Early vs Late Exposure of Water Post-cutaneous Surgeries : A Randomized Controlled Trial

This randomized controlled trial aims to compare the effect of early versus delayed water exposure after cutaneous surgeries on the incidence of surgical site infections. Patients undergoing elective cutaneous surgical procedures will be randomly assigned to either early postoperative water exposure within 48 hours or delayed exposure after 7 days. Wound outcomes will be assessed using the Southampton Wound Grading System during follow-up visits. The study seeks to determine whether early water exposure is safe and whether it influences postoperative wound healing and infection rates.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

82

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients undergoing elective surgical procedures, such as excision of benign or malignant skin lesions, skin grafts, and skin biopsies.

Exclusion Criteria:

  • 1.Patients on anti-coagulants.

    2.Compromised immune systems e.g. pregnancy, diabetes, immunosuppressive therapies.

    3.Wounds that are located in areas with significant movements (e.g. joints) or that are highly prone to external contaminants (e.g. mucosal surfaces) which might bias result.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Early Water Exposure Group
Participants will be allowed early postoperative wound exposure to water after cutaneous surgery and will be monitored for wound infection and healing outcomes.
Behavioral: Care as usual
Participants will be allowed early exposure of the postoperative wound to water following cutaneous surgery according to the study protocol.
Other Names:
  • Early Post operative Wound care
Behavioral: Care as usual
Participants will follow conventional postoperative wound care instructions with delayed exposure of the surgical wound to water.
Other Names:
  • Standard Post operative wound care
Active Comparator: Standard Wound Care Group
Participants will follow conventional postoperative wound care instructions with delayed water exposure after cutaneous surgery.
Behavioral: Care as usual
Participants will be allowed early exposure of the postoperative wound to water following cutaneous surgery according to the study protocol.
Other Names:
  • Early Post operative Wound care
Behavioral: Care as usual
Participants will follow conventional postoperative wound care instructions with delayed exposure of the surgical wound to water.
Other Names:
  • Standard Post operative wound care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative Surgical Site Infection
Time Frame: 14 days postoperative
Assessment of the frequency of surgical site infection following cutaneous surgery in participants receiving early versus delayed postoperative water exposure.
14 days postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Pak Emirates Military Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

May 6, 2026

First Submitted That Met QC Criteria

May 6, 2026

First Posted (Actual)

May 12, 2026

Study Record Updates

Last Update Posted (Actual)

May 12, 2026

Last Update Submitted That Met QC Criteria

May 6, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PEMH-DERM-2026-01

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Surgical Site Infection (SSI)

Clinical Trials on Care as usual

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe